SHAREHOLDERS' EQUITY |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| SHAREHOLDERS' EQUITY | SHAREHOLDERS' EQUITY As of December 31, 2025, our authorized capital was comprised of 100.0 million shares of common stock and 10.0 million shares of preferred stock. As of December 31, 2025, there were 31.7 million shares of common stock issued and 31.2 million shares of common stock outstanding. We issue shares of our common stock in connection with our 2014 Omnibus Plan. There were 4.4 million shares of common stock authorized under this plan. As of December 31, 2025, we had a remaining balance of 1.3 million shares of common stock available for future grants under this plan. Any shares related to awards that terminate by expiration, forfeiture, cancellation, or otherwise without the issuance of shares, are settled in cash in lieu of shares or are exchanged with the Committee's permission for awards not involving shares and are available again for grant under the 2014 Omnibus Plan. Share Repurchases On May 12, 2025, the Company announced that its Board authorized the repurchase of up to $100.0 million of the Company's common stock subject to certain conditions, in the open market, in block purchases, or in privately negotiated transactions, with the authorization expiring on May 12, 2028. As of December 31, 2025, the Company has repurchased 563,638 shares for an aggregate amount of $30.3 million, including excise taxes and other direct costs. Shares repurchased for purposes other than retirement are accounted for as treasury stock and are recorded as a reduction of shareholders' equity on the Company's Consolidated Balance Sheet.
|